2024 BIO Convention: Advancements in the Life Sciences Sector: Cell and Gene Therapy in Canada

Cell and gene therapies have the promise to cure — not just treat — cancers, heart disease, diabetes, and more. Clinical Trials Ontario, Life Sciences Ontario and Ontario Bioscience Innovation Organization are bringing industry and research leaders together for an event showcasing the importance of cell and gene therapy to the life sciences sector in Canada. The event, taking place on Monday, June 3, 2024 from 8:30am to 10:30am at the BIO International Convention in San Diego, will feature a panel of experts sharing insights and discussing opportunities to position Canada as a go -to destination for cell and gene therapy.

Topics of discussion will include:

• The evolving landscape of cell and gene therapies
• The clinical trials underway testing the safety and efficacy of these treatments
• Canada's infrastructure for producing these advanced therapies

This event is for the pharmaceutical and medical device industries, CROs, business and healthcare innovation leaders doing business in Canada. This networking event showcases the strength of Canada’s science and technology to the world’s biotechnology industry.

Agenda:
7:45 am – Registration and breakfast
8:30 am – Session begins
10:30 am – Session ends

Location:
Marriot Marquis San Diego Marina
San Diego Ballroom A
333 West Harbor Drive, San Diego, CA 92101

Speakers:

Opening Remarks:
Brigitte Nolet, President & CEO, Roche Canada Pharma

Special Remarks:
The Honourable Victor Fedeli, Ontario's Minister of Economic Development, Job Creation and Trade

Moderator:
Michael May, PhD, President & CEO, CCRM

Panelists:
Dr. Stéphanie Michaud, President & CEO, BioCanRx

Cate Murray, President & CEO, Stem Cell Network

Renzo Dicarlo, Vice President, Head of Development, Productivity & Quality, Rare Disease Unit, AstraZeneca

Closing Remarks:
Adam Marsella, Director, Public Affairs, Novo Nordisk